[go: up one dir, main page]

AU2002226674A1 - Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient - Google Patents

Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient

Info

Publication number
AU2002226674A1
AU2002226674A1 AU2002226674A AU2002226674A AU2002226674A1 AU 2002226674 A1 AU2002226674 A1 AU 2002226674A1 AU 2002226674 A AU2002226674 A AU 2002226674A AU 2002226674 A AU2002226674 A AU 2002226674A AU 2002226674 A1 AU2002226674 A1 AU 2002226674A1
Authority
AU
Australia
Prior art keywords
compounds
tricyclic
active ingredient
heterocyclic derivative
drugs containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002226674A
Other versions
AU2002226674B2 (en
Inventor
Yoshifumi Kagamiishi
Hisao Nakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority claimed from PCT/JP2001/011581 external-priority patent/WO2002053565A1/en
Publication of AU2002226674A1 publication Critical patent/AU2002226674A1/en
Application granted granted Critical
Publication of AU2002226674B2 publication Critical patent/AU2002226674B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002226674A 2000-12-28 2001-12-27 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient Ceased AU2002226674B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000402517 2000-12-28
JP2000-402517 2000-12-28
PCT/JP2001/011581 WO2002053565A1 (en) 2000-12-28 2001-12-27 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient

Publications (2)

Publication Number Publication Date
AU2002226674A1 true AU2002226674A1 (en) 2003-01-23
AU2002226674B2 AU2002226674B2 (en) 2007-03-22

Family

ID=18866787

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226674A Ceased AU2002226674B2 (en) 2000-12-28 2001-12-27 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient

Country Status (24)

Country Link
US (3) US7034153B2 (en)
EP (2) EP1354884B1 (en)
JP (2) JP3528968B2 (en)
KR (1) KR100843281B1 (en)
CN (2) CN1274690C (en)
AT (2) ATE375345T1 (en)
AU (1) AU2002226674B2 (en)
BR (1) BR0116609A (en)
CA (1) CA2432148C (en)
CZ (1) CZ20031777A3 (en)
DE (1) DE60130924T2 (en)
DK (1) DK1354884T3 (en)
ES (2) ES2294047T3 (en)
HU (1) HUP0303653A3 (en)
IL (2) IL156609A0 (en)
MX (1) MXPA03005913A (en)
NO (1) NO326522B1 (en)
NZ (1) NZ526712A (en)
PL (1) PL363381A1 (en)
PT (1) PT1354884E (en)
RU (1) RU2291869C2 (en)
TW (1) TWI293630B (en)
WO (1) WO2002053565A1 (en)
ZA (1) ZA200305003B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562965B1 (en) * 2000-07-06 2003-05-13 Bristol-Myers Squibb Pharma Company Convergent synthesis of α-aryl-β-ketonitriles
JP3528968B2 (en) * 2000-12-28 2004-05-24 小野薬品工業株式会社 Tricyclic heterocyclic derivative compound and drug containing the compound as active ingredient
UA80295C2 (en) * 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
US7247628B2 (en) 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7268133B2 (en) 2003-04-23 2007-09-11 Pfizer, Inc. Patent Department Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7232823B2 (en) 2003-06-09 2007-06-19 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
EP1637521B1 (en) * 2003-06-23 2013-06-19 Ono Pharmaceutical Co., Ltd. Novel tricyclic heterocycle compound
TWI356058B (en) 2003-06-25 2012-01-11 Ono Pharmaceutical Co Methanesulfonate salt of pyrazolo-pyrimidine compo
WO2005061508A1 (en) * 2003-12-22 2005-07-07 Ono Pharmaceutical Co., Ltd. Tricyclic heterocyclic compound and medicine containing the compound as active ingredient
WO2005087775A1 (en) * 2004-03-15 2005-09-22 Ono Pharmaceutical Co., Ltd. Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient
JP4857267B2 (en) * 2004-06-30 2012-01-18 アサーシス， インク． Non-imidazole tertiary amines that are histamine 3 receptor inhibitors for the treatment of cognitive impairment, sleep disorders, obesity and other CNS disorders
EP1771169A1 (en) 2004-07-14 2007-04-11 PTC Therapeutics, Inc. Methods for treating hepatitis c
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (en) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Thienopyridine for treating hepatitis C
AR051780A1 (en) * 2004-11-29 2007-02-07 Japan Tobacco Inc FUSIONED RING COMPOUNDS CONTAINING NITROGEN AND USING THEMSELVES
PL1829874T3 (en) * 2004-12-22 2014-07-31 Ono Pharmaceutical Co Tricyclic compound and use thereof
TW200639163A (en) * 2005-02-04 2006-11-16 Genentech Inc RAF inhibitor compounds and methods
UY31604A1 (en) * 2008-01-22 2009-08-31 TRICYCLIC COMPOUNDS AND USE OF THE SAME
RU2369600C1 (en) * 2008-01-24 2009-10-10 Андрей Александрович Иващенко SUBSTITUTED 4-SULPHONYL-PYRAZOLES AND 3-SULPHONYL-PYRAZOLO[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT AND METHOD OF OBTAINING THEM
RU2376291C1 (en) * 2008-05-07 2009-12-20 Андрей Александрович Иващенко SUBSTITUTED 3,5-DIAMINO-4-SULFONYL-PYRAZOLES AND 2-AMINO-3-SULFONYL-PYRAZOLO-[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THEIR PRODUCTION AND USE
EP2248817B1 (en) * 2008-01-24 2015-01-07 Alla Chem, LLC. Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
WO2012012642A1 (en) * 2010-07-22 2012-01-26 Zafgen Corporation Tricyclic compounds and methds of making and using same
US8927562B2 (en) 2010-09-28 2015-01-06 Merck Sharp & Dohme Corp. Fused tricyclic inhibitors of mammalian target of rapamycin
WO2012047569A1 (en) * 2010-09-28 2012-04-12 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
JP5857068B2 (en) * 2010-12-17 2016-02-10 リアタ ファーマシューティカルズ インコーポレイテッド Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
UA113186C2 (en) 2011-09-30 2016-12-26 Macrocyclic LRRK2 Kinase Inhibitors
DK3194405T3 (en) 2014-09-17 2019-04-15 Oncodesign Sa MACROCYCLIC LRRK2 KINase INHIBITORS
US11220510B2 (en) 2018-04-09 2022-01-11 Incyte Corporation Pyrrole tricyclic compounds as A2A / A2B inhibitors
MX2022006853A (en) * 2019-12-03 2022-09-19 Turning Point Therapeutics Inc MACROCYCLES FOR USE IN THE TREATMENT OF DISEASES.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006096A1 (en) * 1990-10-09 1992-04-16 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivative, production thereof, and androgen inhibitor
CA2206080A1 (en) * 1995-09-28 1997-04-03 Otsuka Pharmaceutical Factory, Inc. Analgesic composition_of pryazolo{1,5-a}pyrimidine derivatives
NZ333302A (en) 1996-08-28 2000-08-25 Pfizer Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor
CA2334671A1 (en) 1998-06-09 1999-12-16 Neurogen Corporation Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
WO2000027846A2 (en) 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
JP2002529469A (en) 1998-11-12 2002-09-10 ニューロクライン バイオサイエンシーズ， インコーポレイテッド CRF receptor antagonists and methods related thereto
JP3528968B2 (en) * 2000-12-28 2004-05-24 小野薬品工業株式会社 Tricyclic heterocyclic derivative compound and drug containing the compound as active ingredient

Similar Documents

Publication Publication Date Title
AU2002226674A1 (en) Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
HUP0303653A3 (en) Tricyclic and heterocyclic derivative and pharmaceutical compositions containing them as the active ingredient
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
IL161940A0 (en) Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
PL372084A1 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
IL144592A0 (en) Heterocyclic aromatic compounds and pharmaceutical compositions containing the same
EP1557415A4 (en) Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
AU2002354054A1 (en) Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
AU3053199A (en) Fused thiophene derivatives and drugs containing the same as the active ingredient
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
AU3078000A (en) Heterocyclic compounds and antitumor agents containing the same as the active ingredient
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
AU2001228810A1 (en) Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
AU2001292122A1 (en) Heterocyclic derivatives useful as pharmaceutical agents
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU6016000A (en) Tricyclic compounds and drug compositions containing the same